DCH Should I Buy

JPMorgan reinstated coverage of Dauch with a Neutral rating and $8 price target following a period of restriction in conjunction with the company's acquisition of UK-based Dowlais. While the firm sees a more favorable setup for patient investors starting late 2027 as one-time free cash flow drags taper and synergies increasingly accrue, is sees growth over market remaining a hurdle to re-rating, noting that implied organic growth of down 3% in FY26 guidance compares to global production expected to be down 2% at the time of guidance.